Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
Canon USA has purchased a nearly 20% stake in T2 Biosystems, a maker of time-domain nuclear magnetic resonance diagnostics, for $40 million. T2 has worked with the molecular diagnostics arm of Canon since 2015 to develop a test panel for Lyme disease. T2 expects to use the funds to grow its business and launch a sepsis detection panel in 2017. The firm’s technology was developed by scientists at Massachusetts General Hospital and MIT.
This article has been sent to the following recipient: